TABLE 8.
Current methods for engineering sEVs.
| Engineering on parent cells | Engineering sites | Components | Ref | Engineering on isolated sEVs | Engineering sites | Components | Ref |
|---|---|---|---|---|---|---|---|
| Genetic transfection | Membrane | Membrane proteins | Alvarez-Erviti et al. (2011) | Chemical modifications | Membrane | Cationic lipids, nanoparticles | Nakase and Futaki. (2015); Qi et al. (2016); Tian et al. (2018) |
| EXPLOR | Lumen | Proteins | (Yim et al., 2016; Choi et al., 2020) | Co-incubation | Lumen | Hydrophobic drugs | Pascucci et al. (2014); Wang et al. (2022) |
| Co-culturing | Lumen | Hydrophobic drugs | Pascucci et al. (2014) | Electroporation | Lumen | Antisense oligonucleotides, Cas9 mRNA, and guide RNAs, siRNAs, short hairpin RNAs | Kamerkar et al. (2017); Usman et al. (2018) |
| Cellular nanoporation | Lumen | Therapeutic mRNAs, Targeting peptides | Yang et al. (2020b) | Sonication | Lumen | Hydrophobic drugs | Kim et al. (2018) |
| Ischemic preconditioning | Lumen | MiRNAs | Li et al. (2015) | Extrusion | Lumen | Hydrophobic drugs, Enzymes | Jang et al. (2013); Haney et al. (2015) |
| Inflammatory cytokines | Lumen | MiRNAs | Domenis et al. (2018) | Saponin-assistant permeabilization | Lumen | Hydrophilic drugs | Fuhrmann et al. (2015) |
| Lipid-assistant chemical transfection | Lumen | SiRNAs | Shtam et al. (2013) | ||||
| Hydrophobic modification | Lumen | SiRNAs | Didiot et al. (2016) |